Kaplan-Meier survival analysis revealed that high RCC1 and SGOL2 expression correlated with poorer survival outcomes in breast and lung cancer patients (p =  0.00014 for breast cancer, p =  3.2e-07 for lung cancer) (Fig 4A, B, D, E). This evidence concerns the gene RCC1 and lung cancer.